MXPA05002337A - Formulacion medicinal en aerosol, estabilizada con agua. - Google Patents
Formulacion medicinal en aerosol, estabilizada con agua.Info
- Publication number
- MXPA05002337A MXPA05002337A MXPA05002337A MXPA05002337A MXPA05002337A MX PA05002337 A MXPA05002337 A MX PA05002337A MX PA05002337 A MXPA05002337 A MX PA05002337A MX PA05002337 A MXPA05002337 A MX PA05002337A MX PA05002337 A MXPA05002337 A MX PA05002337A
- Authority
- MX
- Mexico
- Prior art keywords
- medicinal aerosol
- related applications
- aerosol formulation
- water stabilized
- stabilized medicinal
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003380 propellant Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/234,825 US7074388B2 (en) | 1998-12-10 | 2002-09-03 | Water stabilized medicinal aerosol formulation |
| PCT/US2003/027245 WO2004022035A1 (en) | 2002-09-03 | 2003-09-03 | Water stabilized medicinal aerosol formulation related applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05002337A true MXPA05002337A (es) | 2005-12-05 |
Family
ID=31977472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05002337A MXPA05002337A (es) | 2002-09-03 | 2003-09-03 | Formulacion medicinal en aerosol, estabilizada con agua. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7074388B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1569617A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006502160A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003272251A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2497171C (cg-RX-API-DMAC7.html) |
| DE (1) | DE03754425T1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2247959T1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05002337A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004022035A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60133203T3 (de) * | 2000-07-31 | 2012-02-23 | Nycomed Danmark Aps | Fentanyl Zusammensetzung für nasale Anwendung |
| EP1415647A1 (en) * | 2002-10-23 | 2004-05-06 | CHIESI FARMACEUTICI S.p.A. | "Long-acting beta-2 agonists ultrafine formulations" |
| ES2304616T3 (es) * | 2003-03-20 | 2008-10-16 | Boehringer Ingelheim Pharmaceuticals Inc. | Formulacion para un inhalador con dosis medida utilizando hidro-fluoro-alcanos como propulsores. |
| US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
| US20060178394A1 (en) * | 2003-04-14 | 2006-08-10 | Staniforth John N | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
| AR041873A1 (es) * | 2003-10-30 | 2005-06-01 | Pablo Cassara Srl Lab | Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante |
| GB0501956D0 (en) * | 2005-01-31 | 2005-03-09 | Arrow Internat | Nebulizer formulation |
| GB0604141D0 (en) * | 2006-03-01 | 2006-04-12 | Arrow Int Ltd | Nebulizer formulation |
| WO2009049159A1 (en) | 2007-10-10 | 2009-04-16 | Parion Sciences, Inc. | Delivering osmolytes by nasal cannula |
| WO2011034883A2 (en) * | 2009-09-15 | 2011-03-24 | Union Carbide Chemicals & Plastics Technology Llc (Formerly Union Carbide Chemicals & Plastics Technology Corporation) | Personal care compositions with ethylene acrylic acid copolymer aqueous dispersions |
| GB0918149D0 (en) * | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
| WO2012061195A2 (en) | 2010-11-04 | 2012-05-10 | Union Carbide Chemicals & Plastics Technology Llc | Skin care compositions |
| EP2717855A4 (en) | 2011-06-07 | 2014-11-12 | Parion Sciences Inc | Methods of Treatment |
| US8945605B2 (en) | 2011-06-07 | 2015-02-03 | Parion Sciences, Inc. | Aerosol delivery systems, compositions and methods |
| JP2017505348A (ja) | 2014-02-10 | 2017-02-16 | パタラ ファーマ リミテッド ライアビリティ カンパニー | 肺疾患治療のための肥満細胞安定剤 |
| PL3104853T3 (pl) | 2014-02-10 | 2020-05-18 | Respivant Sciences Gmbh | Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych |
| US10265296B2 (en) | 2015-08-07 | 2019-04-23 | Respivant Sciences Gmbh | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders |
| WO2017027387A1 (en) | 2015-08-07 | 2017-02-16 | Patara Pharma, LLC | Methods for the treatment of mast cell related disorders with mast cell stabilizers |
| JP2019528320A (ja) | 2016-08-31 | 2019-10-10 | レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ | 特発性肺線維症による慢性咳の治療のためのクロモリン組成物 |
| EP3522983A4 (en) | 2016-10-07 | 2020-06-03 | Respivant Sciences GmbH | CROMOLYN COMPOSITION FOR TREATING LUNG FIBROSIS |
| WO2019235616A1 (ja) | 2018-06-08 | 2019-12-12 | 東興薬品工業株式会社 | フルチカゾンフランカルボン酸エステル点鼻組成物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9202519D0 (en) * | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
| DE4446891A1 (de) * | 1994-12-27 | 1996-07-04 | Falk Pharma Gmbh | Stabile wäßrige Budesonid-Lösung |
| US6458338B1 (en) * | 1998-09-22 | 2002-10-01 | Aeropharm Technology Incorporated | Amino acid stabilized medicinal aerosol formulations |
| DE19847969A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Lagerfähig flüssige Formulierung mit Formoterol |
| US6261539B1 (en) * | 1998-12-10 | 2001-07-17 | Akwete Adjei | Medicinal aerosol formulation |
| US6540983B1 (en) * | 2000-01-25 | 2003-04-01 | Aeropharm Technology Incorporated | Medical aerosol formulation |
| US6548049B1 (en) * | 2000-05-01 | 2003-04-15 | Aeropharm Technology Incorporated | Medicinal aerosol formulation |
| US6565833B1 (en) * | 2000-05-01 | 2003-05-20 | Aeropharm Technology Incorporated | Medicinal aerosol formulation |
| US6447750B1 (en) * | 2000-05-01 | 2002-09-10 | Aeropharm Technology Incorporated | Medicinal aerosol formulation |
-
2002
- 2002-09-03 US US10/234,825 patent/US7074388B2/en not_active Expired - Fee Related
-
2003
- 2003-09-03 MX MXPA05002337A patent/MXPA05002337A/es unknown
- 2003-09-03 ES ES03754425T patent/ES2247959T1/es active Pending
- 2003-09-03 WO PCT/US2003/027245 patent/WO2004022035A1/en not_active Ceased
- 2003-09-03 JP JP2004534386A patent/JP2006502160A/ja active Pending
- 2003-09-03 CA CA002497171A patent/CA2497171C/en not_active Expired - Fee Related
- 2003-09-03 DE DE03754425T patent/DE03754425T1/de active Pending
- 2003-09-03 AU AU2003272251A patent/AU2003272251A1/en not_active Abandoned
- 2003-09-03 EP EP03754425A patent/EP1569617A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ES2247959T1 (es) | 2006-03-16 |
| JP2006502160A (ja) | 2006-01-19 |
| AU2003272251A1 (en) | 2004-03-29 |
| EP1569617A1 (en) | 2005-09-07 |
| DE03754425T1 (de) | 2006-03-09 |
| CA2497171A1 (en) | 2004-03-18 |
| WO2004022035A1 (en) | 2004-03-18 |
| US20030091512A1 (en) | 2003-05-15 |
| CA2497171C (en) | 2009-04-28 |
| US7074388B2 (en) | 2006-07-11 |
| EP1569617A4 (en) | 2010-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6136294C1 (en) | Amino acid stabilized medical aerosol formulation | |
| MXPA03000442A (es) | Una formulacion medicinal en aerosol. | |
| EP1135173A4 (en) | MEDICINAL AEROSOL FORMULATION | |
| CA2497171A1 (en) | Water stabilized medicinal aerosol formulation | |
| IL164699A (en) | Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient | |
| IL138767A0 (en) | Anticancer compositions | |
| EA200600696A1 (ru) | Фармацевтические композиции для предотвращения передозировки или неправильного употребления лекарственных средств | |
| YU68199A (sh) | Farmaceutske formulacije koje sadrže vorikonazol | |
| IL168266A (en) | Nucleoside derivatives, processes for their preparation. pharmaceutical compositions comprising them and uses thereof for the manufacture of medicaments | |
| DE60031504D1 (de) | Fluticasonpropionat arzneizubereitung | |
| DK0717617T3 (da) | Mikropartikler indeholdende aktive bestanddele og gas | |
| DE60019167D1 (de) | Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason | |
| EA200500909A1 (ru) | Модифицированное высвобождение фармацевтической композиции | |
| IL162214A (en) | Pyridine derivatives and pharmaceutical compositions containing the same | |
| MXPA03008420A (es) | Forma farmaceutica solida oralmente dispersa. | |
| WO2004091591A3 (fr) | Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives | |
| WO2005065639A3 (en) | Novel pharmaceutical compositions | |
| DK1355906T3 (da) | 2H-1-benzopyranderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende dem | |
| WO2002007672A3 (en) | A medicinal aerosol formulation | |
| AP2001002369A0 (en) | Pharmaceutical complex. | |
| AU2502301A (en) | Medicament and combination of compatible medicaments | |
| WO2001039741A3 (de) | Mitomycin c-lösung | |
| UA32354A (uk) | Антиангінальний засіб у формі аерозолю | |
| IL162857A0 (en) | Oral vaccination | |
| AU2003288214A1 (en) | Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient |